An orthotopic prostate cancer model for new treatment development using syngeneic or patient-derived tumors.

Naz ChaudaryE WiljerWarren FoltzPratibha ThapaRichard P HillMichael Milosevic

Published in: The Prostate (2024)

This novel preclinical orthotopic prostate cancer mouse model is suitable for either syngeneic or patient derived tumors and will be effective in developing and advancing the current selection of treatments for patients with prostate cancer.

Keyphrases

prostate cancer
radical prostatectomy
mouse model
stem cells
bone marrow
cell therapy
combination therapy